#mCOMBRIAX

Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19 mCOMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's fourth authorized product mCOMBRIAX will be ...

#Moderna groß in Form! Nach dem #mNexspike (Nachfolger von Spikevax) hat die EU jetzt auch den Kombi-Impfstoff #mCOMBRIAX gegen #Covid und #Influenza zugelassen.
www.accessnewswire.com/newsroom/en/...
#TeamVorsicht #ImpfenSchuetzt
1/2

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax The Moderna vaccine will likely be available in Europe long before the US.

USA Food and Drug Agency declined to review #mCombriax

Europe will be first to have access to the first #combo mRNA #vaccine for #FLU-Covid for 50+ crowd.

The EMA - European Medicines Agency

First combined COVID-19 and influenza vaccine for people 50 years and older | European Medicines Agency (EMA) mCombriax helps to protect against both COVID-19 caused by SARS-CoV-2 and seasonal influenza

One shot, two targets: @ema.europa.eu just recommended market authorization for #mCombriax, the first combined COVID-19/flu vaccine for people 50+. Trial (~8,000 participants) found antibody responses comparable to getting the COVID and flu vaccines separately.

www.ema.europa.eu/en/news/firs...